Corvus Pharmaceuticals Inc Phase 3 Anti-CD73 Update Call Transcript
Greetings. Welcome to the Corvus Pharmaceuticals conference call. (Operator Instructions) Please note, this conference is being recorded. I will now turn the conference over to your host, Zack Kubow of Real Chemistry. Thank you. You may begin.
Thank you, operator, and good afternoon, everyone. Thank you for joining us for the Corvus Pharmaceuticals conference call to discuss an update on mupadolimab and other topics. Joining me on the call from the company are Dr. Richard Miller, Chief Executive Officer; Leiv Lea, Chief Financial Officer; and Dr. Mehrdad Mobasher, Chief Medical Officer. The executive team will open the call with some prepared remarks followed by a question-and-answer period.
I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by those statements
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
